obagi nu-derm fx system normal - dry skin transformation complexion brightening system

Generic: homosalate, octisalate, and zinc oxide

Labeler: obagi cosmeceuticals llc
NDC Directory HUMAN OTC DRUG UNAPPROVED DRUG OTHER Inactive Finished

Drug Facts

Product Profile

Brand Name obagi nu-derm fx system normal - dry skin transformation complexion brightening system
Generic Name homosalate, octisalate, and zinc oxide
Labeler obagi cosmeceuticals llc
Dosage Form KIT
Manufacturer
Obagi Cosmeceuticals LLC

Identifiers & Regulatory

Product NDC 62032-539
Product ID 62032-539_0ad34be9-6f0d-446b-8131-94f8e5f453b9
Product Type HUMAN OTC DRUG
Marketing Category UNAPPROVED DRUG OTHER
Listing Expiration 2026-12-31
Marketing Start 2019-12-02

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62032539
Hyphenated Format 62032-539

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name obagi nu-derm fx system normal - dry skin transformation complexion brightening system (source: ndc)
Generic Name homosalate, octisalate, and zinc oxide (source: ndc)

Resolved Composition

Strengths
  • 10 %
  • 5 %
  • 16.5 %
source: label
Packaging
  • 1 KIT in 1 CARTON (62032-539-07) * 57 g in 1 BOTTLE, PLASTIC * 57 g in 1 BOTTLE, PLASTIC * 48 g in 1 BOTTLE, PLASTIC * 85 g in 1 TUBE * 57 g in 1 BOTTLE, PLASTIC * 198 mL in 1 BOTTLE, PLASTIC * 198 mL in 1 BOTTLE, PLASTIC
source: ndc

Packages (1)

62032-539-07 1 KIT in 1 CARTON (62032-539-07) * 57 g in 1 BOTTLE, PLASTIC * 57 g in 1 BOTTLE, PLASTIC * 48 g in 1 BOTTLE, PLASTIC * 85 g in 1 TUBE * 57 g in 1 BOTTLE, PLASTIC * 198 mL in 1 BOTTLE, PLASTIC * 198 mL in 1 BOTTLE, PLASTIC

Ingredients (0)

No ingredient records.

Linked Drug Pages (1)

Obagi Nu-Derm FX System Normal - Dry Skin Transformation Complexion Brightening System ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"spl_id": "0ad34be9-6f0d-446b-8131-94f8e5f453b9", "openfda": {"spl_set_id": ["512b20f0-60c8-47d4-a732-22fc999980d3"], "manufacturer_name": ["Obagi Cosmeceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 KIT in 1 CARTON (62032-539-07)  *  57 g in 1 BOTTLE, PLASTIC *  57 g in 1 BOTTLE, PLASTIC *  48 g in 1 BOTTLE, PLASTIC *  85 g in 1 TUBE *  57 g in 1 BOTTLE, PLASTIC *  198 mL in 1 BOTTLE, PLASTIC *  198 mL in 1 BOTTLE, PLASTIC", "package_ndc": "62032-539-07", "marketing_start_date": "20191202"}], "brand_name": "Obagi Nu-Derm FX System Normal - Dry Skin Transformation Complexion Brightening System", "product_id": "62032-539_0ad34be9-6f0d-446b-8131-94f8e5f453b9", "dosage_form": "KIT", "product_ndc": "62032-539", "generic_name": "Homosalate, Octisalate, and Zinc Oxide", "labeler_name": "Obagi Cosmeceuticals LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Obagi Nu-Derm FX System Normal - Dry", "brand_name_suffix": "Skin Transformation Complexion Brightening System", "marketing_category": "UNAPPROVED DRUG OTHER", "marketing_start_date": "20191202", "listing_expiration_date": "20261231"}